Skip to content

Circadian Rhythm Disruption in the Hospital Intensive Care Environment

Circadian Rhythm Disruption in the Hospital Intensive Care Environment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05828680
Enrollment
15
Registered
2023-04-25
Start date
2023-03-15
Completion date
2028-12-01
Last updated
2026-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Surgery

Brief summary

Abrupt changes to one's lifestyle disrupt biorhythms. Acute effects are well known from jet lag where transmeridian travel leads to insomnia, fatigue, irritability, gastrointestinal symptoms and other complaints. Several studies in the hospital environment reported dampened and misaligned biorhythms, suggesting that the inpatient experience is replete with circadian disruptors. However, comprehensive assessments of how circadian clocks are affected in intensive care and how this predicts post-operative recovery and risk are largely missing.

Interventions

OTHERObservation

No intervention

Sponsors

University of Pennsylvania
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Adults scheduled for cardiac surgery; * ≥18 years of age; * Capable of giving informed consent; * Own a smartphone (Apple devices only).

Exclusion criteria

* Taking sleep aids (antihistamines, melatonin, etc.) * History of alcohol abuse (more than 2 drinks a day with last drink within the past 3 days) * History of substance abuse at risk of postoperative withdrawal; * Active diagnosis of alcohol or substance abuse; * Recent travel across more than two (2) time zones (within the past month); * Planned travel across more than two (2) time zones during the planned study activities; * Subjects, who have received an experimental drug, used an experimental medical device within 30 days prior to screening, or who gave a blood donation of ≥ one pint within 8 weeks prior to screening; * Subjects without access to WiFi in their or close to home or at work; * Patients with hearing aids; * Heart transplant patients; * Patients in isolation.

Design outcomes

Primary

MeasureTime frameDescription
Sleep depthUp to 48 hoursVariance in sleep depth assessed as percent REM sleep of total sleep time (TST)

Secondary

MeasureTime frameDescription
Odds Ratio Product-based sleep depthUp to 48 hoursVariance in sleep depth assessed as Odds Ratio Product (ORP) which ranges between ORP=0 (deeply asleep) and ORB=2.5 (fully awake).
Cognitive function assessed by the Montreal Cognitive Assessment (MoCA)Up to 24 hoursVariance in cognitive function
Number of recorded patient visits24 hoursAny patient visits by physicians, nurses, maintenance and cleaning staff, family members and friends are documented
Purpose of recorded patient visits24 hoursThe rationale is documented descriptively for each patient visits by physicians, nurses, maintenance and cleaning staff, family members and friends

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORCarsten Skarke, MD

University of Pennsylvania

PRINCIPAL_INVESTIGATORGarret A FitzGerald, MD

University of Pennsylvania

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 23, 2026